Byrne Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.3K Hold
1,090
0.05% 253
2026
Q1
$94.4K Sell
1,090
-15
-1% -$1.44K 0.06% 234
2025
Q4
$106K Buy
+1,105
New +$107K 0.06% 217
2025
Q3
Sell
-1,105
Closed -$102K 158
2025
Q2
$96.3K Hold
1,105
0.06% 157
2025
Q1
$99.3K Sell
1,105
-25
-2% -$2.24K 0.07% 149
2024
Q4
$90.3K Sell
1,130
-190
-14% -$16.4K 0.06% 155
2024
Q3
$119K Sell
1,320
-110
-8% -$9.25K 0.08% 144
2024
Q2
$113K Sell
1,430
-430
-23% -$35.3K 0.08% 146
2024
Q1
$162K Buy
1,860
+30
+2% +$2.56K 0.11% 124
2023
Q4
$151K Buy
+1,830
New +$139K 0.11% 123
2023
Q3
Sell
-1,545
Closed -$129K 128
2023
Q2
$136K Buy
+1,545
New +$133K 0.09% 170
2022
Q4
Sell
-225
Closed -$18K 541
2022
Q3
$18K Sell
225
-100
-31% -$8.99K 0.01% 303
2022
Q2
$29K Hold
325
0.02% 235
2022
Q1
$36K Hold
325
0.02% 240
2021
Q4
$34K Buy
+325
New +$37.6K 0.02% 243

Other funds holding MDT

Byrne Asset Management's MDT Position: Q2 2026 in Review

Byrne Asset Management held its Medtronic (MDT) position steady in Q2 2026 at 1,090 shares worth $85.3K. The position accounts for 0.05% of the portfolio, ranked #253.

Byrne Asset Management first reported a position in MDT in Q4 2021 and has held it in 15 quarters since. The position peaked at $162K in Q1 2024. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Byrne Asset Management held 1,090 shares of Medtronic worth $85.3K as of Q2 2026.
  • Byrne Asset Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.05% of Byrne Asset Management's portfolio in Q2 2026, its #253 holding.
  • Byrne Asset Management first reported a position in Medtronic in Q4 2021 and has held it in 15 quarters since.
  • Byrne Asset Management's Medtronic position peaked at $162K in Q1 2024.
  • 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.